Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- R&D NEWS IN BRIEF
February 18, 2008
- MEDICAL FACILITIES & NURSING CARE NEWS IN BRIEF
February 18, 2008
- Taiyo Completes Expansion of Its Production Facilities
February 18, 2008
- Aricept, Pariet/AcipHex Drive Eisai's Business
February 18, 2008
- Towa to Establish Overnight Delivery System via Network of Hansha
February 18, 2008
- Nobelpharma to Launch 3 New Drugs
February 18, 2008
- Survey／COPD Awareness Rate Remains Unchanged at 34%: NBI/Pfizer Survey
February 18, 2008
- Takara Bio to Launch World's First Protein Regulation System
February 18, 2008
- GENERICS NEWS IN BRIEF
February 18, 2008
- Korosho to Send Missions to the US, UK and France
February 18, 2008
- SELF-MEDICATION NEWS IN BRIEF
February 18, 2008
- JPMA to Cooperate in Reduction in CO2 Emission
February 18, 2008
- Requirements for Self-injection of IFN, Etanercept Relaxed
February 18, 2008
- BUSINESS NEWS IN BRIEF
February 18, 2008
- Kyushu Medical Association Decides to Support Dr Karasawa
February 18, 2008
- Herceptin Approved for Postoperative Adjuvant Chemotherapy
February 18, 2008
- Takeda to Use Amgen Japanas Development Subsidiary
February 18, 2008
- No Problems Found in EPPV of Velcade, Alimta
February 18, 2008
- Objection to Use of Literature by MRs without Obtaining Prior Consent
February 18, 2008
- REGULATORY NEWS IN BRIEF
February 18, 2008
ページ
Japan is ramping up its push to spread regional formularies nationwide, a policy expected to standardize treatments, strengthen supply resilience,…
We had just gotten off a call with a client in Europe, and we’d received a bit of an earful. “Philip,” the client pressed, “what can this candidate bring to us? We know what he does, but what has he…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…